Wockhardt informs about press release

21 Jan 2019 Evaluate

Wockhardt has informed about submission of proposed Press Release titled ‘Wockhardt Receives US FDA Approval for Leukemia drug’.

The above information is a part of company’s filings submitted to BSE.

Wockhardt Share Price

1518.60 72.85 (5.04%)
03-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1849.10
Dr. Reddys Lab 1352.75
Cipla 1510.25
Lupin 2367.85
Zydus Lifesciences 975.55
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.